Back to Home

Payer Strategy & Market Dynamics

Expert articles and analysis related to payer strategy & market dynamics.

41 articles•Last 24 Hours

AI Summary — Last 24 Hours

CMS finalized a 2.48% payment increase for Medicare Advantage (MA) in 2027—up from the initial 0.09% proposal—injecting an estimated $13 billion in additional payments to MA organizations and immediately driving insurer stock surges. At the same time, finalized Part D risk adjustment updates for 2027 will alter plan payments, further segmenting MA-PDs and PDPs, and signaling significant near-term shifts in payer strategy, competitive positioning, and risk model incentives for value-based care operators. Stakeholders should anticipate both intensified focus on MA growth dynamics and evolving responses in population health and risk-bearing arrangements.

Related Articles

90ALN

In a first, a drugmaker’s lawsuit challenges HRSA’s 340B patient definition

In a new chapter for litigation involving the 340B Drug Pricing Program, a drugmaker is suing the federal government over the definition of patient as it pertains to the program. AbbVie Inc. says the ...

HFMAApr 9, 2026
90ALN

Recent 340B Court Rulings Sustain Blocked WV Law, Demand Decade-Old Federal Policy Be Set Aside

InsideHealthPolicy reports that a federal court ruled in favor of Premier Inc., vacating a decade-old HRSA policy limiting how certain 340B hospitals purchase drugs through group purchasing organizati...

PremierApr 9, 2026
90ALN

Trump promised to clamp down on health insurers. His policies are enriching them - statnews.com

Trump promised to clamp down on health insurers. His policies are enriching them  statnews.com

news.google.comApr 9, 2026
80ALN

California Attorney General Reinforces State’s Corporate Practice of Medicine Prohibition in Amicus Filing

Hooper LundyApr 9, 2026
80ALN

Mississippi 340B law upheld by appeals court in two cases

Mississippi 340B law upheld by appeals court in two cases  American Hospital Association

AHAApr 9, 2026
80ALN

Opinion | He Was an Insurance Executive. She’s a Doctor. They’re Divided.

Opinion | He Was an Insurance Executive. She’s a Doctor. They’re Divided.  Health Leaders Media

Health LeadersApr 9, 2026
80ALN

Washington State Ousted This Health Insurance Lookalike. In Oregon, It Carries On.

Washington State Ousted This Health Insurance Lookalike. In Oregon, It Carries On.  Health Leaders Media

Health LeadersApr 9, 2026
80ALN

Eli Lilly launches oral GLP-1 drug across US through Lilly Direct, telehealth providers

Eli Lilly launches oral GLP-1 drug across US through Lilly Direct, telehealth providers  Fierce Healthcare

Fierce HealthcareApr 9, 2026
80ALN

Abortion Pill’s Safety Called into Question in Congressional Actions Based on Misleading Data — The Monitor

False claims about the safety of mifepristone are driving legislative and investigative action in Congress, even as major medical organizations and decades of clinical evidence support the drug’s safe...

KFFApr 9, 2026
80ALN

Farm Bureau Plans Are a Less Pricey Alternative to ACA Coverage — With Trade-Offs

Fourteen states now allow health coverage through state farm bureaus. Though they generally share many features of Affordable Care Act marketplace plans, they aren’t insurance. Neither are they typica...

KFF Health NewsApr 9, 2026